Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced the appointment of Thomas (Tommy) Leggett as Chief Financial Officer (CFO).
September 12, 2019
· 4 min read